Mitesco Financial Statements From 2010 to 2025
MITI Stock | USD 0.62 0.03 5.08% |
Check Mitesco financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mitesco's main balance sheet or income statement drivers, such as , as well as many indicators such as . Mitesco financial statements analysis is a perfect complement when working with Mitesco Valuation or Volatility modules.
Mitesco |
Mitesco Company Return On Asset Analysis
Mitesco's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Mitesco Return On Asset | -0.77 |
Most of Mitesco's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mitesco is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition |
Based on the latest financial disclosure, Mitesco has a Return On Asset of -0.7715. This is 91.18% lower than that of the Healthcare sector and significantly lower than that of the Health Information Services industry. The return on asset for all United States stocks is notably higher than that of the company.
Mitesco Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mitesco's current stock value. Our valuation model uses many indicators to compare Mitesco value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mitesco competition to find correlations between indicators driving Mitesco's intrinsic value. More Info.Mitesco is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Mitesco by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Mitesco's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Mitesco Financial Statements
Investors use fundamental indicators, such as Mitesco's revenue or net income, to determine how well the company is positioned to perform in the future. Although Mitesco's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Mitesco, Inc. operates medical clinics under the The Good Clinic name in North East Minneapolis, the United States. The company was formerly known as True Nature Holding, Inc. and changed its name to Mitesco, Inc. in April 2020. Mitesco operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 27 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Mitesco Pink Sheet
Mitesco financial ratios help investors to determine whether Mitesco Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mitesco with respect to the benefits of owning Mitesco security.